A-share pharmaceutical stocks fluctuated higher in the morning, with CRO, recombinant protein, innovative drugs and other concepts leading the gains; Medicilon rose more than 16%, Bidex Pharmaceuticals rose more than 7%, and Zhaoyan Pharmaceutical, S

2025-07-09

A-share pharmaceutical stocks fluctuated higher in the morning, with CRO, recombinant protein, innovative drugs and other concepts leading the gains; Medicilon rose more than 16%, Bidex Pharmaceuticals rose more than 7%, and Zhaoyan Pharmaceutical, Sunshine Novo, Northrop Grumman and other stocks followed suit. The National Development and Reform Commission stated that since the 14th Five-Year Plan, 402 new drugs have been added to the national medical insurance drug list.